Chi‐Ping Day

机构：National Institutes of Health, National Cancer Institute, National Cancer Institute, Center for Cancer Research · ORCID：0000-0001-5200-2372

发表论文 172 篇 · 总被引 3190 次 · h-index 24

代表论文

• Longitudinal liquid biopsy identifies an early predictive biomarker of immune checkpoint blockade response in head and neck squamous cell carcinoma (2025 · Nature Communications · 被引 14)
• Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells (2026 · Science Translational Medicine · 被引 10)
• CRISPR‐Based Gene Dependency Screens Reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid Cancer (2026 · Molecular Carcinogenesis · 被引 2)
• Long-read sequencing of single cell-derived melanoma subclones reveals divergent and parallel genomic and epigenomic evolutionary trajectories (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)
• Data from Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways (2025 · 被引 1)
• A machine learning model reveals expansive downregulation of ligand-receptor interactions enhancing lymphocyte infiltration in melanoma with developed resistance to Immune Checkpoint Blockade (2026 · Zenodo (CERN European Organization for Nuclear Research))